Abstract
As the indications for recombinant human growth hormone (r-hGH) treatment have expanded, the number of patients receiving r-hGH has increased and injectable delivery of r-hGH is likely to be required for the foreseeable future. Continued innovations in the ease of use, safety and reliability of r-hGH devices have already gone some way to making GH treatment less stressful for patients, both physically and psychologically. Adherence with r-hGH remains a problem, which may be alleviated by offering free patient choice. In addition development of electronic auto-injectors now also provides the potential for monitoring adherence both for healthcare professionals, and also aiding patients in administering and monitoring their own GH injections.
Keywords: Growth hormone, easypod, Growth hormone deficiency, somatropin
Current Drug Therapy
Title: Developments in Growth Hormone Delivery
Volume: 5 Issue: 1
Author(s): Jeremy Kirk
Affiliation:
Keywords: Growth hormone, easypod, Growth hormone deficiency, somatropin
Abstract: As the indications for recombinant human growth hormone (r-hGH) treatment have expanded, the number of patients receiving r-hGH has increased and injectable delivery of r-hGH is likely to be required for the foreseeable future. Continued innovations in the ease of use, safety and reliability of r-hGH devices have already gone some way to making GH treatment less stressful for patients, both physically and psychologically. Adherence with r-hGH remains a problem, which may be alleviated by offering free patient choice. In addition development of electronic auto-injectors now also provides the potential for monitoring adherence both for healthcare professionals, and also aiding patients in administering and monitoring their own GH injections.
Export Options
About this article
Cite this article as:
Kirk Jeremy, Developments in Growth Hormone Delivery, Current Drug Therapy 2010; 5 (1) . https://dx.doi.org/10.2174/1574885511005010043
DOI https://dx.doi.org/10.2174/1574885511005010043 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Food Addiction and Neuroimaging
Current Pharmaceutical Design Child Abuse and Neglect and its Psycho-Physical and Social Consequences: A Review of the Literature
Current Pediatric Reviews Lipoprotein(a) Management: Pharmacological and Apheretic Treatment
Current Medicinal Chemistry Targeted Therapy for Advanced Renal Cell Cancer: Cytokines and Beyond
Current Pharmaceutical Design Peptide-Derived Protease-Activated Receptor-1 (PAR-1) Antagonists
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Deubiquitinating Enzymes as Therapeutic Targets in Cancer
Current Pharmaceutical Design Evolution of Antipsychotic Intervention in the Schizophrenic Psychosis
Current Drug Targets Meet Our Regional Editor
Mini-Reviews in Medicinal Chemistry Angiogenesis as Risk Factor for Plaque Vulnerability
Current Pharmaceutical Design Meet Our Editorial Board Member:
Current Drug Targets Depressive Symptoms, Assessment, and Treatment in Latino/a Adolescents: A Brief Review
Current Psychiatry Reviews Update on MDS Therapy: From Famine to Feast
Cardiovascular & Hematological Agents in Medicinal Chemistry Ketogenic Diets in the Treatment of Epilepsy
Current Pharmaceutical Design Pharmacological Implications of MMP-9 Inhibition by ACE Inhibitors
Current Medicinal Chemistry State of the Art of the Therapeutic Perspective of Sorafenib Against Hematological Malignancies
Current Medicinal Chemistry Molecular Pathways Involved in the Early and Late Damage Induced by Testis Ischemia: Evidence for a Rational Pharmacological Modulation
Current Medicinal Chemistry Turning the Clock Ahead: Potential Preclinical and Clinical Neuropharmacological Targets for Alcohol Dependence
Current Pharmaceutical Design BACE1 Structure and Function in Health and Alzheimers Disease
Current Alzheimer Research Lentiviral Vectors for Gene Therapy of HIV-1 Infection
Current Gene Therapy Currently Used Antimycotics: Spectrum, Mode of Action and Resistance Occurrence
Current Drug Targets